GUK1激活是肺癌中的代谢负担
Jaime L Schneider1, Kiran Kurmi2, Yutong Dai3
1Department of Cell Biology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA; Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Boston, MA, USA.
在肺癌中,无细胞淋巴瘤激酶 (ALK) 信号驱动着酸酶1 (GUK1) 酸化,增加了酸二 (GDP) 合成. 针对GUK1可能为癌基因驱动的肺癌提供新的治疗策略.
科学领域:
- 癌症学
- 分子生物学
- 癌症新陈代谢
背景情况:
- 瘤基因驱动的肺癌的代谢脆弱性在很大程度上尚未被探索.
- 无细胞淋巴瘤激酶 (ALK) 的重组是肺癌的一个主要驱动因素.
研究的目的:
- 在肺癌中识别ALK信号的代谢点.
- 研究酸酶1 (GUK1) 在ALK驱动的肺癌中的作用.
主要方法:
- 在ALK重组 (ALK+) 患者衍生的细胞系中进行选.
- 对ALK+患者瘤样本的空间成像.
- 使用GUK1变体进行体外和体内功能测试.
主要成果:
- 关酸激酶1 (GUK1) 被确定为ALK信号的直接目标.
- 在素74 (Y74) 处化GUK1,增强瓜诺辛二酸盐 (GDP) 生物合成.
- GUK1酸化与关氨酸核酸水平相关,并通过MAPK信号驱动瘤增殖.
结论:
- 在肺癌中,GUK1 是由ALK信号调节的关键代谢节点.
- 抑制GUK1酸化可降低瘤的生长,并可能是治疗策略.
- 在肺癌中,GUK1酸化也受到其他致癌融合蛋白的调节.
更多相关视频
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
09:38Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure
Published on: August 11, 2017
相关概念视频
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
GPCRs Regulate Adenylyl Cylase Activity
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Abnormal Proliferation
Mitogens and the Cell Cycle
